Get the Stockscreener App
2.6808
1.29%
-0.0392
Aerovate Therapeutics Inc stock is traded at $2.6808, with a volume of 135.28K.
It is down -1.29% in the last 24 hours and up +30.98% over the past month.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
See More
Previous Close:
$2.72
Open:
$2.73
24h Volume:
135.28K
Relative Volume:
0.18
Market Cap:
$76.21M
Revenue:
-
Net Income/Loss:
$-75.52M
P/E Ratio:
-1.0311
EPS:
-2.6
Net Cash Flow:
$-56.92M
1W Performance:
+18.81%
1M Performance:
+30.98%
6M Performance:
-86.77%
1Y Performance:
-76.59%
1-Day Range:
$2.60
$2.74
1-Week Range:
$2.19
$3.00
52-Week Range:
$1.25
$32.41
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
Name
Aerovate Therapeutics Inc
Sector
Industry
Phone
617-443-2400
Address
930 WINTER STREET, WALTHAM
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Dec-06-22 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-19-22 | Resumed | Wedbush | Outperform |
| Aug-16-22 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-11-22 | Initiated | BTIG Research | Buy |
| Jul-26-21 | Initiated | Cowen | Outperform |
| Jul-26-21 | Initiated | Evercore ISI | Outperform |
| Jul-26-21 | Initiated | Jefferies | Buy |
| Jul-26-21 | Initiated | Wedbush | Outperform |
View All
Aerovate Therapeutics Inc Stock (AVTE) Latest News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire
Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World
How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve
Finansavisen - Finansavisen
SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow
Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Jade Biosciences and Aerovate announce merger deal - Investing.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Aerovate climbs on all-stock merger deal with Jade - MSN
Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat
Aerovate Therapeutics regains Nasdaq compliance - Investing.com India
Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail
Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World
Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat
Aerovate Therapeutics announces board member resignation - Investing.com India
Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK
XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat
Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes
Why AeroVironment Shares Are Flying Higher Today - sharewise
Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World
AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
AeroVironment Inc. (AVAV): Why Are Short Sellers Betting Against This Defense Tech Leader? - Insider Monkey
Recent Insider Activity Suggests Potential Gains for Aerovate Therapeutics Inc (AVTE) - Knox Daily
Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World
Quest Partners LLC Increases Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World
Alignment healthcare CEO sells shares worth over $1m - Investing.com
Aerovate Therapeutics Inc Stock (AVTE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):